Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
NAFFIC, AWARE claim first China-EU DPP for textiles- Bad flu season getting worse; skyrocketing cases set state record
- Watch This Glacier Race into the Sea
- 2 of Earth's rarest lightning phenomena captured simultaneously in once-in-a-lifetime photo
- A trip to Colombia in my 20s turned into 8 years freelancing in South America. Here's what I'd do differently.
- Astronomers discover never-before-seen celestial object: "Cloud 9"
- New dietary guidelines recommend more dairy, meat and fats: What to know
- The Best Portable Applications for Emotional wellness and Prosperity
- Audits of the Top Science fiction Movies This Year
